FDA takes aim at Hims and other telehealth services in drug advertising blitz
NegativeHealth

The FDA has launched a crackdown on telehealth services like Hims, warning them about advertising unofficial versions of popular medications, including Wegovy, a leading obesity treatment. This move is significant as it highlights the growing concern over the safety and regulation of online health services, which have surged in popularity. The implications of these warnings could reshape how telehealth companies operate and ensure that patients receive safe and approved treatments.
— Curated by the World Pulse Now AI Editorial System